Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06221670
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-24
First Post:
2024-01-14
Brief Title:
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations EGFR or ALK
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-03-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-20
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-14
First Submit QC Date:
January 14 2024
Study First Post Date:
2024-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-14
Last Update Post Date:
2024-01-24
Last Update Post Date Type:
ACTUAL